Replies to post #171356 on Biotech Values

[DewDiligence]

TEVA tops ENDP's buyout bid for PATH:

http://www.fiercebiotech.com/story/troubled-teva-offers-surprise-rival-bid-nupathe/2014-01-08

Until this is resolved, I'm removing PATH from the table of biotech buyouts kept in the iBox of this message board.